Hosted on MSN1mon
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatmentThe Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback